search
Back to results

Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers

Primary Purpose

Chronic Venous Disease

Status
Completed
Phase
Phase 2
Locations
Ireland
Study Type
Interventional
Intervention
VASGARD stimulator
Compression bandaging
Sponsored by
Professor Stewart Walsh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Venous Disease focused on measuring Venous ulceration, Leg ulcers, Venous haemodynamics, Surface neuromuscular electrical stimulation, SNMES

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Primary or recurrent venous leg ulcer.
  • Ankle-brachial pressure index > 0.8
  • Ulcer size between 1 and 200 cm2
  • Patient suitable for full compression bandaging

Exclusion Criteria:

  • History of symptomatic heart disease.
  • Pregnancy
  • Presence of implants in the lower leg or a pacemaker
  • History of a neurological disorder
  • Presence of any contraindications for the use of compression stockings such as severe arterial disease i.e. Ankle brachial pressure index (ABPI) <0.8
  • Presence of cognitive difficulties which may prevent the patient or his/her carer from using the stimulator appropriately.
  • Patients unable to provide informed consent
  • Patients receiving dialysis
  • Patients receiving steroids
  • Patients receiving methotrexate
  • Ulcer located in the area of electrode placement
  • Patients in reduced compression bandaging system

Sites / Locations

  • Department of Electronic Engineering, National University Ireland Galway
  • MidWestern Regional Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control group

VASGARD stimulator

Arm Description

Patients randomised to the control group will, in addition to their routine compression bandaging, be given muscle stimulators for home use and instructed to apply 3x 30 minute sessions of comfortable electrical stimulation daily for 12 weeks. The stimulators given to the control group will be set to provide minimal stimulation resulting in no visible muscular contraction.

Patients randomised to this group, in addition to their routine treatment with compression bandaging, will be given muscle stimulators for home use and instructed to apply 3x 30 minute sessions of comfortable electrical stimulation daily for 12 weeks. The intervention group stimulators will be capable of causing muscular contraction with a maximum force ranging from 30-40% of voluntary contractions.

Outcomes

Primary Outcome Measures

Reduction in venous ulcer size
Reduction in relative ulcer size (area) for each patient over time, standardised to an initial size of 1, will be measured weekly.

Secondary Outcome Measures

Acceptability of surface neuromuscular electrical stimulation
Patient and healthcare provider perceptions of the acceptability, efficacy and tolerability of the device will be evaluated through a series of semi-structured interviews

Full Information

First Posted
February 25, 2013
Last Updated
December 11, 2014
Sponsor
Professor Stewart Walsh
search

1. Study Identification

Unique Protocol Identification Number
NCT01801891
Brief Title
Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers
Official Title
Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers: A Randomised Controlled Trial of the "VASGARD" Device
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
May 2013 (undefined)
Primary Completion Date
September 2014 (Actual)
Study Completion Date
October 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Professor Stewart Walsh

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study aims to determine if the use of surface neuromuscular electrical stimulation, applied to various motor points on the lower limb to elicit muscle contraction when combined with compression bandaging accelerates the rate of venous leg ulcer healing.
Detailed Description
With an increasingly ageing population the incidence of venous ulceration is likely to rise. The negative impact of leg ulceration on patients' quality of life and on healthcare costs is well recognised. Increased prevalence combined with poor reported healing rates and high incidence of ulcer recurrence makes the development of a new treatment which could accelerate healing rates beyond that currently achieved using compression bandaging most desirable. Surface neuromuscular electrical stimulation in combination with compression bandaging may provide such a treatment. Surface neuromuscular electrical stimulation (SNMES) is the application of an electrical stimulus to motor points in the body using electrodes placed on the surface of the skin to elicit a muscular contraction. It has been shown that SNMES of the calf muscles, when used in conjunction with compression therapy, provides improved venous flow velocities over compression therapy alone. Furthermore, the week-long effect of SNMES and compression therapy on healthy participants was found to be well tolerated by all participants and resulted in increases in stimulated venous flow and muscle strength. A combined SNMES and compression treatment protocol which stimulates peripheral venous blood flow may help to alleviate harmful venous pressures in venous leg ulcer patients and provide some degree of strengthening of the calf muscles, thus helping to accelerate the healing rates of venous ulcers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Venous Disease
Keywords
Venous ulceration, Leg ulcers, Venous haemodynamics, Surface neuromuscular electrical stimulation, SNMES

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Patients randomised to the control group will, in addition to their routine compression bandaging, be given muscle stimulators for home use and instructed to apply 3x 30 minute sessions of comfortable electrical stimulation daily for 12 weeks. The stimulators given to the control group will be set to provide minimal stimulation resulting in no visible muscular contraction.
Arm Title
VASGARD stimulator
Arm Type
Experimental
Arm Description
Patients randomised to this group, in addition to their routine treatment with compression bandaging, will be given muscle stimulators for home use and instructed to apply 3x 30 minute sessions of comfortable electrical stimulation daily for 12 weeks. The intervention group stimulators will be capable of causing muscular contraction with a maximum force ranging from 30-40% of voluntary contractions.
Intervention Type
Device
Intervention Name(s)
VASGARD stimulator
Other Intervention Name(s)
SNMES
Intervention Description
The VASGARD device is a 2 channel muscle stimulator system designed for increasing venous blood flow. Controlled electrical stimuli are delivered to the patient through adhesive gel electrodes placed over the motor points of muscles on the lower leg. This elicits artificial muscular contractions which in turn increases lower limb venous haemodynamics.
Intervention Type
Other
Intervention Name(s)
Compression bandaging
Other Intervention Name(s)
Graduated compression bandaging
Intervention Description
Compression bandaging systems apply graduated external pressure to the lower limb to promote venous return to the heart reducing venous hypertension and thereby facilitate venous ulcer healing.
Primary Outcome Measure Information:
Title
Reduction in venous ulcer size
Description
Reduction in relative ulcer size (area) for each patient over time, standardised to an initial size of 1, will be measured weekly.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Acceptability of surface neuromuscular electrical stimulation
Description
Patient and healthcare provider perceptions of the acceptability, efficacy and tolerability of the device will be evaluated through a series of semi-structured interviews
Time Frame
12 weeks
Other Pre-specified Outcome Measures:
Title
Changes in skin condition related to the application of Vasgard surface neuromuscular electrical stimulator as a measure of safety and tolerability.
Description
The safety issues associated with using electrical stimulation on this patient group under compression bandaging will be evaluated. The following safety points will be evaluated at each visit. Appearance of the skin under the electrodes (intact / reddened / broken) Appearance of skin surrounding the electrodes (intact / reddened /broken) Appearance of skin under the electrodes leads (intact / reddened / broken
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Primary or recurrent venous leg ulcer. Ankle-brachial pressure index > 0.8 Ulcer size between 1 and 200 cm2 Patient suitable for full compression bandaging Exclusion Criteria: History of symptomatic heart disease. Pregnancy Presence of implants in the lower leg or a pacemaker History of a neurological disorder Presence of any contraindications for the use of compression stockings such as severe arterial disease i.e. Ankle brachial pressure index (ABPI) <0.8 Presence of cognitive difficulties which may prevent the patient or his/her carer from using the stimulator appropriately. Patients unable to provide informed consent Patients receiving dialysis Patients receiving steroids Patients receiving methotrexate Ulcer located in the area of electrode placement Patients in reduced compression bandaging system
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierce A Grace, MCh FRCSI
Organizational Affiliation
HSE
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Electronic Engineering, National University Ireland Galway
City
Galway
ZIP/Postal Code
000
Country
Ireland
Facility Name
MidWestern Regional Hospital
City
Limerick
ZIP/Postal Code
000
Country
Ireland

12. IPD Sharing Statement

Learn more about this trial

Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers

We'll reach out to this number within 24 hrs